DXCM
Dexcom Inc
$72.38
+1.13 (+1.59%)
At close · Jul 6
Market Cap
$27.93B
Shares
385,872,977
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-05-28 | 2026-05-27 | |
| 8-K | 2026-05-15 | 2026-05-14 | |
| 10-Q | 2026-04-30 | 2026-03-31 | |
| 8-K | 2026-04-30 | — | |
| DEF 14A | 2026-04-15 | 2026-05-27 | |
| 8-K | 2026-03-02 | 2026-02-27 | |
| 8-K | 2026-02-26 | — | |
| 10-K | 2026-02-12 | 2025-12-31 | |
| 8-K | 2026-02-12 | — | |
| 8-K | 2026-01-12 | 2026-01-07 | |
| 8-K | 2025-12-22 | 2025-12-19 | |
| 8-K | 2025-10-30 | — | |
| 10-Q | 2025-10-30 | 2025-09-30 | |
| 8-K | 2025-10-27 | 2025-10-24 | |
| 8-K | 2025-09-16 | 2025-09-14 | |
| 8-K | 2025-07-30 | 2025-07-25 | |
| 10-Q | 2025-07-30 | 2025-06-30 | |
| 8-K | 2025-05-13 | 2025-05-09 | |
| 8-K/A | 2025-05-09 | 2025-03-06 | |
| 8-K | 2025-05-09 | 2025-05-08 | |
| 8-K | 2025-05-02 | 2025-05-01 | |
| 10-Q | 2025-05-01 | 2025-03-31 | |
| 8-K | 2025-05-01 | — | |
| DEF 14A | 2025-03-27 | 2025-05-08 | |
| 8-K | 2025-03-25 | 2025-03-21 | |
| 8-K | 2025-03-10 | 2025-03-06 | |
| 8-K | 2025-03-07 | 2025-03-04 | |
| 10-K | 2025-02-18 | 2024-12-31 | |
| 8-K | 2025-02-13 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-12-23 | 2024-12-20 | |
| 10-Q | 2024-10-24 | 2024-09-30 | |
| 8-K | 2024-10-24 | — | |
| 10-Q | 2024-07-25 | 2024-06-30 | |
| 8-K | 2024-07-25 | — | |
| 8-K | 2024-05-24 | 2024-05-22 | |
| 8-K | 2024-04-25 | — | |
| 10-Q | 2024-04-25 | 2024-03-31 | |
| DEF 14A | 2024-04-22 | 2024-05-22 | |
| 8-K | 2024-02-15 | 2024-02-13 | |
| 8-K | 2024-02-08 | — | |
| 10-K | 2024-02-08 | 2023-12-31 | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-11-02 | 2023-10-31 | |
| 8-K | 2023-10-26 | — | |
| 8-K | 2023-10-26 | 2023-10-24 | |
| 10-Q | 2023-10-26 | 2023-09-30 | |
| 8-K | 2023-08-28 | 2023-08-24 | |
| 10-Q | 2023-07-27 | 2023-06-30 | |
| 8-K | 2023-07-27 | — |
Showing 1–50 of 117 filings
Key facts
CIK
1093557
CUSIP
252131107
13F (30d)
59 filings
20 filers
Visit website
Investor relations